FDA Inspection 1135801 — B. Todd Chappel, MD
The FDA completed an inspection of B. Todd Chappel, MD on January 29, 2021 in Memphis, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 29, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Memphis, TN (United States)
Additional Details
Clinical Investigator (CI)